Stalking influenza by vaccination with pre-fusion headless HA mini-stem

Inaccuracies in prediction of circulating viral strain genotypes and the possibility of novel reassortants causing a pandemic outbreak necessitate the development of an anti-influenza vaccine with increased breadth of protection and potential for rapid production and deployment. The hemagglutinin (HA) stem is a promising target for universal influenza vaccine as stem-specific antibodies have the potential to be broadly cross-reactive towards different HA subtypes. Here, we report the design of a bacterially expressed polypeptide that mimics a H5 HA stem by protein minimization to focus the antibody response towards the HA stem. The HA mini-stem folds as a trimer mimicking the HA prefusion conformation. It is resistant to thermal/chemical stress, and it binds to conformation-specific, HA stem-directed broadly neutralizing antibodies with high affinity. Mice vaccinated with the group 1 HA mini-stems are protected from morbidity and mortality against lethal challenge by both group 1 (H5 and H1) and group 2 (H3) influenza viruses, the first report of cross-group protection. Passive transfer of immune serum demonstrates the protection is mediated by stem-specific antibodies. Furthermore, antibodies indudced by these HA stems have broad HA reactivity, yet they do not have antibody-dependent enhancement activity.

[1]  D. Higgins,et al.  See Blockindiscussions, Blockinstats, Blockinand Blockinauthor Blockinprofiles Blockinfor Blockinthis Blockinpublication Clustal: Blockina Blockinpackage Blockinfor Blockinperforming Multiple Blockinsequence Blockinalignment Blockinon Blockina Minicomputer Article Blockin Blockinin Blockin , 2022 .

[2]  M. Mazanec,et al.  Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies , 1995, Journal of virology.

[3]  A. Surolia,et al.  Thermodynamic characterization of the reversible, two-state unfolding of maltose binding protein, a large two-domain protein. , 1997, Biochemistry.

[4]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[5]  W. Gerhard.  The role of the antibody response in influenza virus infection. , 2001, Current topics in microbiology and immunology.

[6]  S. Grzesiek,et al.  Very fast folding and association of a trimerization domain from bacteriophage T4 fibritin. , 2004, Journal of molecular biology.

[7]  R. Varadarajan,et al.  Protein minimization of the gp120 binding region of human CD4. , 2005, Biochemistry.

[8]  Ian A. Wilson,et al.  Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus , 2006, Science.

[9]  R. Weiss,et al.  A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies , 2007, Influenza and other respiratory viruses.

[10]  Gira Bhabha,et al.  Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.

[11]  Boguslaw Stec,et al.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses , 2009, Nature Structural &Molecular Biology.

[12]  John Steel,et al.  Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain , 2010, mBio.

[13]  G. Nabel,et al.  Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination , 2010, Science.

[14]  Ying Gao,et al.  Bioinformatics Applications Note Sequence Analysis Cd-hit Suite: a Web Server for Clustering and Comparing Biological Sequences , 2022 .

[15]  R. Varadarajan,et al.  Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge , 2010, Proceedings of the National Academy of Sciences.

[16]  Martin H. Koldijk,et al.  A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses , 2011, Science.

[17]  J. Skehel,et al.  A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.

[18]  I. Wilson,et al.  A Virus-Like Particle That Elicits Cross-Reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin , 2012, Journal of Virology.

[19]  R. Ahmed,et al.  Re-Engaging Cross-Reactive Memory B Cells: The Influenza Puzzle , 2012, Front. Immun..

[20]  R. Varadarajan,et al.  Design of Escherichia coli-Expressed Stalk Domain Immunogens of H1N1 Hemagglutinin That Protect Mice from Lethal Challenge , 2012, Journal of Virology.

[21]  R. Hai,et al.  Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice , 2012, Journal of Virology.

[22]  E. Böttcher-Friebertshäuser,et al.  The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes , 2013, Journal of molecular and genetic medicine : an international journal of biomedical research.

[23]  K. Laurie,et al.  Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies , 2013, The Journal of Immunology.

[24]  R. Hai,et al.  Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies , 2013, PloS one.

[25]  A. Vincent,et al.  Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease , 2013, Science Translational Medicine.

[26]  R. Hai,et al.  Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies , 2013, Journal of Virology.

[27]  Giuseppe Del Giudice,et al.  The history of MF59® adjuvant: a phoenix that arose from the ashes , 2013, Expert review of vaccines.

[28]  P. Palese,et al.  Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo , 2014, Nature Medicine.

[29]  R. Varadarajan,et al.  Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection , 2014, Proceedings of the National Academy of Sciences.

[30]  Gregory M. Frank,et al.  Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages , 2014, Journal of Virology.

[31]  R. Varadarajan,et al.  Immunogen design for HIV-1 and influenza. , 2014, Biochimica et biophysica acta.

[32]  G. Gao,et al.  Bat-derived influenza-like viruses H17N10 and H18N11 , 2014, Trends in Microbiology.

[33]  T. Waldmann,et al.  IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection , 2014, Proceedings of the National Academy of Sciences.

[34]  Adrian Apetri,et al.  A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen , 2015, Science.

[35]  I. Margine,et al.  Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses. , 2015, Vaccine.

[36]  J. Mascola,et al.  Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection , 2015, Nature Medicine.

[37]  R. Varadarajan,et al.  Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype , 2015, Front. Immunol..

[38]  G. Rimmelzwaan,et al.  Universal influenza vaccines, science fiction or soon reality? , 2015, Expert review of vaccines.